LITTLE FALLS, N.J.,
April 16, 2014 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that
its Senior Vice President, Chief Financial Officer and Treasurer,
Craig Sheldon, will retire after 20
years with the Company in January
2015. In order to ensure a smooth transition, a search
process for a new Chief Financial Officer will commence
immediately.
Charles Diker, Cantel's Chairman
of the Board stated, "Craig has been an integral part of the
success of Cantel Medical for the past 20 years as the Company has
transformed into a global leader in infection prevention and
control. Furthermore, Craig has built a first class finance and
accounting organization with a strong infrastructure of employees
that has served Cantel well while integrating over 25 acquisitions.
We extend our great thanks and appreciation to Craig for 20 years
of excellent, dedicated and loyal service to Cantel."
Andrew Krakauer, Cantel's
President and CEO added, "We are pleased that Craig has agreed to
stay until at least January 2015,
while we search for a new CFO. Furthermore, he has agreed to stay
beyond January if needed and will also sign a 2-year consulting
agreement to assure a smooth transition to a new CFO. I would like
to personally thank Craig for all the critical support he has given
to me over my almost 10 year tenure with Cantel."
Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
SOURCE Cantel Medical Corp.